The latest update is out from Gentian Diagnostics ASA ( (DE:6FK) ).
Gentian Diagnostics ASA, a company involved in the diagnostics industry, has announced a proposed dividend of NOK 0.40 per share for the financial year 2024. This decision, pending approval at the General Meeting, reflects the company’s financial performance and commitment to returning value to shareholders, with key dates set for May 2025.
More about Gentian Diagnostics ASA
YTD Price Performance: 22.50%
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: €62.33M
For an in-depth examination of 6FK stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com